Catherine Frelin - Concepedia

Author

Catherine Frelin

University of Toronto

Also Known As

C Frelin, C. Frelin, Catherine Frelin

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Toronto University Health Network Inserm Ontario Institute for Cancer Research Princess Margaret Cancer Centre

About

Catherine Frelin is an author at University of Toronto specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Cell Biology	7	7	513
3	Health Sciences	2	2	208
4	Natural Sciences	1	1	23
5	Biology	1	1	23

Catherine Frelin

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Self-renewal as a therapeutic target in human colorectal cancer Antonija Kreso, Peter van Galen, Nicholas Pedley, Nature Medicine MedicinePathologyColorectal CancerHuman Colorectal CancerOncology	2013	531
CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells Elisa Laurenti, Catherine Frelin, Stephanie Z. Xie, Cell stem cell	2015	323
Intermediate-Term Hematopoietic Stem Cells with Extended but Time-Limited Reconstitution Potential Patricia Benveniste, Catherine Frelin, Salima Janmohamed, Cell stem cell Developmental BiologyMedicineStem Cell MobilizationAdult Stem CellHematology	2010	192
Targeting NF- B activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells Catherine Frelin Blood	2004	144
GATA-3 regulates the self-renewal of long-term hematopoietic stem cells Catherine Frelin, Robert Herrington, Salima Janmohamed, Nature Immunology Developmental BiologyMedicineStem Cell MobilizationAdult Stem CellStem Cell Research	2013	102
AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells Catherine Frelin, Véronique Imbert, Emmanuel Griessinger, Oncogene CytokineSignaling PathwayApoptosisImmune RegulationImmunology	2003	68
NF‐κB inhibition triggers death of imatinib‐sensitive and imatinib‐resistant chronic myeloid leukemia cells including T315I Bcr‐Abl mutants Nadia Lounnas, Catherine Frelin, Nadège Gonthier, International Journal of Cancer	2009	59
Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival Olivia Cochet, Catherine Frelin, Jean‐François Peyron, Cellular Signalling Signal TransductionStat ProteinsSignaling PathwayConstitutive ActivationReceptor Tyrosine Kinase	2005	55
Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector V. Busuttil, Virginie Bottero, Catherine Frelin, Oncogene Survival AgentCancer ImmunosurveillanceImmune RegulationImmunologyTumor Immunity	2002	50
Inhibition of the NF-κB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-κB essential modulator NEMO Catherine Frelin, Véronique Imbert, Virginie Bottero, Cell Death and Differentiation InflammationCytokineSignal TransductionSignaling PathwayCell Regulation	2007	30

Page 1